TickerFactsScreenerDevelopers

Cue Biopharma, Inc. (CUE) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2017: -$12.14M2018: -$26.41M2019: -$30.80M2020: -$32.49M2021: -$38.84M2022: -$41.81M2023: -$39.96M2024: -$36.33M2025: -$21.69M-$21.69M
2017Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$21.69M+40.3%
2024-$36.33M+9.1%
2023-$39.96M+4.4%
2022-$41.81M-7.6%
2021-$38.84M-19.5%
2020-$32.49M-5.5%
2019-$30.80M-16.6%
2018-$26.41M-117.5%
2017-$12.14M—